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The Brindled variant mouse (Mo ) is a neurological
mutant mouse with a deficiency in copper transport (Hunt et
al., 1974). The male of this sex-linked inherited disease
survives for 14 days postnatally and has, in many respects,
features common to the Menkes Kinky Hair Disease (MKHD) in
humans. As in the case of MKHD, only male hemizygotes are
affected but female heterozygotes show irregularly mottled
color of their fur, as observed in the skin of a Black feamle
that gave birth to an infant with MKHD.
With the use of gel electrophoresis the banding pattern
of intestinal cell membrane proteins from Mo^^ (Mo^^ male,
Mo^^ female) mice were compared to those of the Black agouti
type (normal littermates). When a difference in extracted
protein components of the membranes compared was found, we
further attempted to characterize this difference in the
following ways (a) the individual protein bands were removed
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from the gels, concentrated and rechromatographed to ensure
identity and purity, (b) where there was a quantitative dif¬
ference in the electrophoresed protein bands, these bands
were also treated as in (a) above, (c) the protein was evalua¬
ted for (i) carbohydrate and lipid components; (ii) copper
binding, (iii) zinc binding, (d) anti-bodies to the normal
br*
and Mo male (aberrant) proteins were prepared and the rabbit
was used as the antibody producer, (e) these anti-bodies were
injected into the mouse arterial system which supplies the
upper small intestine. After a few hours, tests were run to
ascertain the ability of the infected Black Agouti mouse to
ascertain the ability of the infected Black Agouti mouse to
transport copper across the intestinal mucosa into the blood.
biT
When we discovered a protein to be missing from the Mo
male samples, the Ouchterlony method was used to determine
bi*
whether the protein was truly deleted from the Mo male mouse
or if there were structural alterations that caused the dif¬
ference in electrophoretic behavior (band in another position).
There are other tests that could have been done to determine
the specific biochemical abnormality but these would require
a very large number of progeny and current facilities do not
allow for such a colony and the lack of predictability of the
numbers of male hemizygotes per litter also argues against
these at this time. A reasonable solution would be to set up
the maintenance stocks of the Brindled strain and collect the
data over a longer period of time. We are reporting the dis¬
covery of a biochemical marker that is related to the genetic
iii
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The malabsorption of copper as a primary cause of Menkes'
Kinky_Hair Syndrome (MKHS) was first reported by Danks et al.
in 1972. This disorder is an X-linked inherited progressive
neurological disease that is fatal. In human’s, the disease
is characterized by growth retardation, cerebral degeneration,
and abnormal hair referred to as kinky or steely hair.
In 1972, Danks et al. detected a copper deficiency in
individuals with this disease and suggested that this was per¬
haps due to a malabsorption of copper in the intestinal tract.
Danks et al. (1973) later reported that although the uptake of
copper into the epithelial cells from the gut lumen was normal,
the transport of copper from the intestinal mucosal cells into
the blood stream was reduced. This finding provided adequate
explanation for the gross copper deficiency that is character¬
istic of this disease.
The male Brindled variant of the mottled mutant mouse of
this sex-linked inherited disease is known to survive for 14
days postnatally, without any special copper treatment. Since
copper deficiency has been shown to underlie the human X-linked
progressive brain disease, and, too, since the mottled mutant
mouse has been shown to have a similar disorder, the mottled
mouse syndrome was chosen as a model to help elucidate some of
the biochemical, dietary and therapeutic problems surrounding
Menkes' Kinky-Hair Syndrome. After the detection of copper
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deficiency in man, early investigators attempted to raise
plasma copper with intravenous copper therapy. Although
successful in raising plasma copper levels to normal, there
was no sustained improvement in the clinical state. Copper
toxicity was and still is prolematic when administered either
parenterally or intramuscularly. The majority of experiments
or reports were concerned with children in which the clinical
manifestation had reached an irreversible stage. But in 1975,
Grover and Scrutton on the advice of Cyril L. Moore, treated
an infant, with this syndrome. The diagnosis was made at the
age of 3 days. This early diagnosis suggests that copper
storage and/or availability was inadequate during fetal life,
or that there was another undiscovered parameter in this
disease. Copper therapy on this infant who was six years of
age when last reported on, provided evidence to support the
thesis that early copper therapy may be beneficial in the pro¬
longation of life. It is true, however, that in spite of the
increased life span, the neurologic deficits were only minimally
reversed by this therapy, although the blood copper, cerulo¬
plasmin and cytochrome oxidase levels remain normalized in the
absence of continued copper therapy.
The effect of copper deficiency in the human and mutant
mouse has been shown to be on the copper-requiring enzymes.
For example, brain cytochrome oxidase is affected more than
liver or muscle cytochrome oxidase, the former dropping as low
as 10% to 15% of normal, while the latter falls to 20-30%.
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There is a substantial drop (%) in the activity of the
copper containing enzyme, tyrosinase. This can explain the
virtual absence of hair pigmentation, since tyrosinase is the
first enzyme in the melanin biosynthetic pathway.
Ceruloplasmin, another copper containing plasma protein,
is also very low or absent. Although the precise function of
ceruloplasmin is still unknown, it is believed that it is a
copper transport protein which may be important to the main¬
tenance of a proper copper distribution and iron transport.
Another copper requiring enzyme is superoxide dismutase. This
enzyme has a very important function in the metabolism of the
cytologically dangerous superoxide radical, is absent. The
absence of this enzyme may account for the erythrocyte fragility
as reported by French and Moore, (1972).
The deficiency in these enzymes can therefore be directly
related to a deficiency in the amount of available copper
supply. Intraperitoneal copper therapy was the method chosen
to study the effects of copper therapy. Subcutaneous injections
eventually led to the survival of the hemizygous offsprings.
Although, subcutaneously injected copper did lead to the sur¬
vival of the hemizygous males, the extent of survival was re¬
lated to the age at which copper therapy was initiated after
birth. Biochemical and anatomical studies were carried out in
which hemizygous males, hemizygous males that received copper
therapy, normal males, and normal males that also received the
equivalent copper therapy were compared.
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In previous experiments in our laboratory, some copper
containing enzymes were evaluated based on their total acti¬
vity. One of the enzymes monitored was cytochrome oxidase.
This enzyme is the terminal enzyme of the electron transport
chain and is responsible for the transfer of electrons from
substrate to molecular oxygen with the possible formation of
either H2O, OH , or O2 • If cytochrome oxidase is defective,
dysfunctional or substantially decreased in quantity, death
will and does ensue. Another enzyme that was measured was
ceruloplasmin. This enzyme is possibly required in maintain¬
ing the plasma copper and/or responsible for the plasma
transportation of copper. Superoxide dismutase was the third
enzyme that was evaluated. This enzyme catalyzes the dismuta-
tion of superoxide radicals (O2 ' + O2 * + 2H O2 + H202 )f
and is principally localized within erythrocytes. The hydrogen
peroxide is eliminated by the action of glutathione peroxidase.
Superoxide dismutase is important in controlling the activity
of superoxide radicals. The fourth and final enzyme that was
evaluated was tyrosinase, which is a relatively stable mamma¬
lian eyzyme. It catalyzes the conversion of tyrosine to DOPA
and DOPA is subsequently converted to melanin. Without melanin
formation the individual would have the phenotype characteris¬
tic of albinism.
Data have been collected to demonstrate the significance
of copper therapy on the quantity of circulating and peripheral
tissue copper containing enzymes as well as the continued
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Iditsurvival of the Mo male in response to the copper regimen
outlined.
Purpose of Our Research
If kinky hair disease is to be corrected therapeutically
it is important that the blood and peripheral tissue levels
be elevated by some mechanism which would preclude copper
intoxication of the subject as is seen in the copper storage
(Wilson's) disease. This has been achieved by us, by intra-
peritoneal administration of copper to the postnatal animal.
It was established earlier that none of the postnatal routes
of copper administration were truly effective in the human
disease, but, since the neonatal mouse resembles the prenatal
human, it was possible that the routes of copper administra¬
tion in the mouse other than via intestinal absorption did
afford us an opportunity to examine the effect of pregestation-
al and gestational therapy on affected hemizygous males (Mo'^^)
in the mouse disorder.
Some of the questions which we have posed (in previous
experiments) are: (1) What is the effect of copper feeding
during the second and third weeks of gestation in the mouse?
(2) How would this feeding be controlled and the copper levels
in the maternal and fetal blood be monitored? (3) What effects
would early or later postnatal copper therapy have on the
longevity and neurologic competence of the animal? (4) Is the
apparent deficiency of the copper proteins due to a decrease
in the activity of the copper-less protein or to a decrease
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in synthesis of the apoprotein? (5) Does the presence of
systemic copper lead to de novo synthesis or to incorporation
of the copper in a pre-existing enzyme? This last question
is the one that was addressed at the level of copper transport
in the small bowel.
These are some of the questions that have been asked by
our laboratory, and to some of these we have obtained answers
and/or clues.
Specifically, we have found a copper binding protein that
is present in the normal mouse and is absent from the hemizygous
male (Mo“ ) mouse, but, is present in the heterozygous female
(Mo^^) at a lesser concentration than in the normal mouse.
There also seems to be distinct electrophoretically identifi¬
able bands which occur in the hemizygour male in higher con¬




In 1962 John H. Menkes, described a new degenerative
disease of the central nervous system, which he believed to
be caused by a metabolic defect (Menkes, 1962). During a
twelve year period preceding the first publication on Menkes
Kinky-Hair disease (MKHD), Menkes and his colleagues evaluat¬
ed 5 boys from a white family of English-Irish descent. All
five boys were affected with mental retardation and failure
to thrive. After twelve years of evaluation Menkes first
reported that the disease was distinguished by a rapidly
progressive cerebral degeneration, pili torti, failure to
gain weight, white hair, sex-linked recessive transmission
and death before the age of three. Two of the boys were
examined directly by Menkes and his colleagues. Information
on the other three was obtained from medical records and
answers from the family.
In summary of Menkes' first report of this disease,
he implicated that the condition described in his paper
represented a new clinical syndrome that was due to an in¬
herited error in metabolism. In the two cases studied by
Menkes, postmortem examination revealed a widespread dege¬
neration of the cerebral gray matter and secondary degenera¬
tion of the cerebral white matter. He also found a diffuse
atrophy of the cerebellar cortex. Biochemical studies con¬
ducted on one of the boys showed that the levels of glutamic
7
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acid were higher than normal.
Four years later Aguilar et al. reported on six case
studies (Aguilar, 1966). The six boys studied showed clinical
features which were strikingly similar to those described by
Menkes in 1962. Her report was based mainly on the postmortem
studies of the two autopsied cases described. The results
of Menkes were thus confirmed by a second group of investi¬
gators who also described more widespread neuropathological
abnormalities.
The head was reported brachycephalic and small, measur¬
ing 43 cm in circumference (average value for a 12 month old
male is 47 cm). There were bitemporal crainiotomy scars. The
anterior fontanelle was open but small; the bony sutures were
partially closed; the skull was increased in thickness; the dura
was thick and myxoid and there were bilateral subdural membranes
over the convexities. The brain weighed 435 gm (normal weight
935 gm). The cerebrum was small and the folia were narrow.
The coronal sectioning revealed pale firm cortical gray matter
and a decreased amount of white matter with moderate enlarge¬
ment of the lateral ventricles. The cerebellar cortex was pale
and narrow with an indistinct corticomedullary margin. The
upper and lower brain stem and the spinal cord showed no gross
abnormalities.
The sex-linked recessive pattern of inheritance presented
in the reports of both Menkes and Aguilar, demonstrated and
supported well the idea of the disease being sex-linked
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recessive. Further evidence of this disease being sex-linked
recessive came from the finding that in Aguilar's report,
two separate males sired two diseased offsprings with the same
mother.
O'Brien and Sampson in 1966 coined the term Kinky Hair
Disease. In these studies they found a reduction in gray
matter docosahexaenoic acid. This acid is the most highly
unsaturated fatty acid in the brain. O'Brien and Sampson
suggested that this disorder was due to an accumulation within
neurons of oxidized lipids which could disrupt mitochondria
and microsom.al function. As a result of these findings they
proposed a mechanism for the cause of Kinky Hair Disease. They
proposed that products of oxidized lipids were accumulating in
the involved neurons of the Kinky Hair Disease (KHD) patients.
Also that such toxic products were interfering with the meta¬
bolic machinery of such involved cells. Therefore, the pro¬
found neurological changes which occurred in the KHD may be
partially explained by cellular damage or abnormal metabolic
function. They also concluded that there was no reason to
postulate a deficiency of antioxidants in their patients be¬
cause both of them were receiving supplemental levels of
vitamin E and there was no evidence of malabsorption.
Danks et al. published a paper in 1972 proposing copper
to be the primary cause of the disease. They examined seven
new cases of Menkes's Kinky Hair Syndrome. After extensive
study an evaluation was made and they found several things
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that were relevant to Menkes' syndrome. The first was hypo¬
thermia. Hypothermia is a body temperature lower than normal.
They also found low levels of serum copper and ceruloplasmin.
One of the most significant findings made by Menkes was the
discovery of a defect in the intestinal absorption of copper.
For this reason they postulated a copper deficiency due to
defective intestinal absorption of copper as the basic bio¬
chemical defect in Menkes' Syndrome. Furthermore, the recog¬
nition of seven patients within a 3 year period indicated that
this disease may sometimes go undiagnosed. All other clinical
manifestations prior to this report were confirmed in Danks'
report. These findings opened up new avenues of investigation
into the normal mechanism of copper absorption. Later, Danks
suggested that treatment of this serious disease would soon
be possible.
In 1972 Menkes reported hypothermia to be a common symptom
and that pili torti only develops some weeks after birth
thereby, confirming the work by Danks (1972). Oral copper
therapy was administered to one patient in the form of CUCI2.
The results showed an initial rise in serum copper levels
accompanied by a slight clinical improvement. The patient's
temperature stabilized between 36.5 and 37*^0. As a result he
became more active and smiled for the first time. Subsequently
the clinical improvements were noted. It was later postulated
in the same report that because of earlier tests that included
the injection of 80 pg of copper, the clinical improvements
noted may have been due to the injection of copper rather than
the orally administered copper.
In the second case where oral copper was the only copper
therapy used the results were not promising. Soon after
copper was first administered the boy started to take solid
foods. His growth improved, but there was no significant
change in his neurological state. Later when another case
was reported, Danks tried intravenous copper therapy. Attempted
therapy with intravenous cupric chloride (100 ug daily) had to
be discontinued when the second dose caused transient peripheral
cicrulatory failure. The findings of Danks et al. (1972)
appear to establish defective intestinal absorption of copper
and consequent copper deficiency as consistent features of
Menkes' syndrome. This was demonstrated very effectively by
oral administration of copper-64 to two patients. The results
showed diminished absorption in both patients in comparison to
a non-Menkes infant. The collection of stool was incomplete in
one patient, but 75% of the dose was recovered in 48 hours.
In the second case a total stool collection was made. In a
48 hour period 97% of the copper-64 that was administered was
recovered. Menkes suggested that the slight improvement noted
in the first patient could be promising. But therapy will have
to start from or perhaps before birth to be of greatest benefit
to the patient.
In 1972 French et al. examined the possibility of a
defect in antioxidant metabolism. They noted the virtual
12
absence of cytochrome a+ag in brain mitochondria. Cytochrome
a+ag (cytochrome c oxidase) constitutes the terminal complex
or respiratory chain. Cytochrome oxidase also contains both
heme and copper which are essential for its redox function.
This neurodegenerative disease has been reported in previous
papers as Kinky Hair Disease (Aguilar, 1966 and Billings, 1971),
and as a Sex-Linked Recessive Disorder with Retardation of
Growth, Peculiar Hair, and Focal Cerebral and Cerebellar
Degeneration. It has also been referred to as a Sex-Linked
Neurodegenerative Disease Associated with Monilethrix (Bray,
1965). French et al. suggested that this nomenclature is
inappropriate. The first one is inaccurate because the ab¬
normalities are not present in physiologically kinky hair.
The second one is not only cumbersome as is the third, but
only described one of three hair abnormalities. Therefore,
they suggested that "trichopoliodystrophy" most adequately
described this disorder. This name emphasizes the abnormali¬
ties of the hair (Greek Trichos). The Greek word Polis means
gray matter of the nervous system and the Greek words Dys plus
Trophos mean failure to thrive.
In 1973 Danks et al. introduced the term steely-hair to
replace the term kinky-hair which accurately described the
appearance of Menkes syndrome. Microscopically there is pili
torti of the hair. Macroscopically the hair is depigmented
and lustreless, stands on end, and becomes tangled. It looks
and feels quite like steel wool. Therefore, they suggested
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that the name steely-hair should replace the name kinky-hair,
since the old term kinky-hair would cause clinicians to expect
crimpled hair.
Walker-Smith in 1973 discussed the therapeutic implica¬
tions of copper deficiency in Menkes Steely-Hair Syndrome.
In one infant treated, copper EDTA was used as therapy. There
was a rise in plasma copper oxidase, which reflects plasma
ceruloplasmin levels. As a result the state of copper defi¬
ciency was relieved. The rise in plasma copper oxidase levels
indicated that the liver could synthesize ceruloplasmin once
copper was available to it. Since the state of copper is
restored once the gut is by-passed, this supports the view
that the defect in Menkes' Steely-Hair Syndrome is principally
a malabsorption problem. Unfortunately the neurological
sequelae of this disorder was unaffected. Also the neurolo¬
gical sequelar are unlikely to be reversed once a state of
chromic copper deficiency has developed, in the human as well
as in the mutant mouse.
Low brain copper levels were reported in all 3 children
examined. They suggested the possibility that infants with Menke
Steely-Hair Syndrome have adequate copper stores at birth, since
the clinical manifestations of the disease do not appear for a
few months postnatally. Since bile constitutes the main excre¬
tory pathway for copper in man, the enterohepatic circulation of
copper is small. Actually it comprises only the low and readily
diffusible fraction of biliary copper. The reduction or aboli¬
tion of circulatory copper in these infants with copper
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malabsorption would lead them to becoming copper depleted
within a few months after birth. This interval of time would
presumably depend on the size of their copper stores at birth.
However, they do suggest that once the symptoms appear as
they are reported, the onset of convulsion and clinical
deterioration is rapid. It is unlikely that intrauterine
diagnosis will be possible because the infant would be receiv¬
ing adequate copper from his mother. They do suggest that
when there is a family history of a death of a child from
Menkes' syndrome, sexing should be done in early pregnancy and
if the fetus is found to be a male, abortion could be advised.
If plasma copper were estimated serially from birth in
children born into such families there is a chance that early
prenatal copper therapy might be successful in preventing
cerebral damage. They concluded that intramuscular copper
(copper-EDTA) with careful monitoring of plasma copper levels,
offers the best course of treatment at this time. We suggest
however, that the plasma copper level alone is not a good
index.
Prohaska et al., in 1974 used the developing rat brain as
a possible model for Menkes' Steely-Hair disease. The similari¬
ties between Menkes Disease and the copper deficient rat
included slow growth, a slight decrease in whole brain and
cerebellar growth and a highly significant decrease in
myelination based on the activity of cerebellar-2, 3-cyclid
nucleotide 3-phosphohydrolase, a myelin enriched protein.
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Specific effects of a five fold reduction in the copper content
of brain were seen in a drastic decrease in cerebellar cyto¬
chrome c oxidase and smaller but significant decreases in cere¬
bellar superoxide dimutase and brain norepinephrine. They
suggested that a decrease in superoxide dismutase in copper
deficiency may have a deleterious effect on neural tissue.
This could give rise to an increase in lipid peroxidation,
O'Brien and Sampson (1966) reported a decrease in docosahexenoic
acid content, in phosphatidyl ethanolamine and phosphatidyl
serine and suggested an increase in the peroxidation of un¬
saturated lipids in patients with Menkes disease. French et
al., 1972 reported a diminution of unsaturated fatty acids in
white matter, and an increase in hydrogen peroxide hemolysis
of erythrocytes from a patient. Superoxide dimutase has been
shown to play a role in protecting erythrocytes against peroxi-
dative hemolysis (Fee and Teitelbaum, 1972). The role of
superoxide in lipid peroxidation has been reported by Pederson
and Aust (1973).
They all concluded that until further evidence is presented
on reduced brain copper in Menkes disease, the explanation for
aberrant behavior, neuronal damage, increased peroxidation of
lipids based on changes in the copper (metallo) enzymes (super¬
oxide dismutase, cytochrome c oxidase, and dopamine-Beta-
hydroxylase) is still speculation. As Banks in 1972 pointed
out, the brain damage may be the result of arterial disease
caused by the derangement of elastin (O'Dell, 1961).
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Danks in 1974 published a summation of all the findings
of Menkes Syndrome. Also included was a short biographical data
section on himself. He stated that he received his medical
education and pediatric training at the University of Melbourne.
His training in genetics was received in the Medical Research
Council Genetics Research Unit at the Institute of Child Health
in London and the John Hopkins Hospital, Baltimore. Since
1967, Dr. Danks has been a reader in Human Genetics at the
University of Melbourne and Medical Geneticist to the Royal
Children's Hospital Research Foundation.
The rest of his summation basically states, the fault
in Menkes Syndrome appears to lie in the transport of copper
from the intestinal mucosal cell into the blood stream. Up¬
take from the intestinal content into the mucosal cell is pro¬
bably normal (French and Moore, 1972) . This defect results in
copper deficiency of a profound degree which is certainly
established by the age of 5 months and can be safely presumed
to precede the onset of symptoms. Excess of free sulfhydryl
groups has been found in the hair of this disease (Gillespie,
1964). A decrease in cross-links between polypeptide chains
in elastin is probably due to a decrease in the enzyme which
is responsible for the cross-links. Their results showed this
enzyme to be amine oxidase. Amine oxidase is a copper dependent
enzyme which is responsible for the cross-links between poly¬
peptide chain in elastin (Carnes, 1971).
The bonds are formed between lysine residues. The lesions
seen in the arterial wall are very similar to those described
in spontaneous or induced copper deficiency in domestic and
experimental animals. A decrease in cross-links between poly¬
peptide chains in elastin could also be explained by a defici¬
ency of lysyl oxidase, which is also a copper containing enzyme.
In fact lysyl oxidase was blamed for this very thing in the
paper by Underwood et al. (1971). The depigmentation of hair
is presumably the result of deficient tyrosinase activity.
The results presented in the paper by Hunt (1974), showed
that a primary defect in copper transport underlies the mottled
syndrome in the mouse. The X-linked mottled mutants thus offer
an excellent system for study of mammalian copper metabolism.
Therefore, they concluded that these animals would make an
excellent model for the inherited human copper deficiency pre¬
sented here, Menkes Kinky-Hair Disease.
A number of different mutant alleles at the mottled
locus are known and these include the Blotchy (Mo° °), Brindled
(Mo^^), Dappled (Mo^^), Mottled (Mo), and the Viable-brindled
(Mo’^^^) . In all cases where the male hemizygote survives
beyond birth, the resulting mouse shows a severe dilution in
hair pigment. The individual hair has altered hair structure
and the whiskers are curly. Estimates of liver and brain
copper in 10 day-old brindies revealed a deficiency. There
was an accumulation of copper in the intestinal wall. This
indicates that uptake from the gut lumen is normal but that
the general body deficiency arises from a defective transport
within the intestinal epithelium or mucosal cells or across
the membrane on the serosal aspect of these cells. This inter¬
pretation was tested and proven. The results confirmed that
the initial uptake into the intestinal epithelium is not de¬
fective.
Copper levels are depressed in liver and serum and the
accumulation of copper in the intestinal epithelium directly
parellels that in the human disease. The phenotypic variega¬
tion arises from random X inactivation in female heterozy¬
gotes for an X-linked coat-color mutant which depends on the
cells autonomy of the mutant defect. Copper deficient cells
would be expected to be at a selective disadvantage in com¬
petition with their normal counterparts (Grunebert, 1969),
thus leading to a progressive dilution of mutant cells during
development. This is supported by the progressive darkening of
brindled heterozygotes with age (Grover, 1975),
Later in 1974 more extensive work was done to detect
ceruloplasmin levels in kinky hair disease patients (Matsuda,
1974). Matsuda et al. used the radioimmunoassay technique to
detect apoceruloplasmin. This technique can detect as little
as 1.0 ng of apoceruloplasmin. Their results revealed that in
infants with Menkes Kinky-Hair, apoceruloplasmin levels
(1.4 ± 0.5 mg per 100 ml) differed significantly from normal
(3.3 to 3.1 mg per 100 ml) infants. These findings suggested that
apoceruloplasmin synthesis does not continue at a normal rate with
a reduced availability of copper. The holoceruloplasmin was vir¬
tually undetectable. Within 2 weeks after oral administration of
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copper in an infant with nutritional copper deficiency, holo-
ceruloplasmin concentration was increased to 30 mg per 100 ml
of plasma, but apoceruloplasmin concentration remained unchanged.
This evidence further supports the idea that apoceruloplasmin
synthesis continues at a low rate and holoceruloplasmin syn¬
thesis is almost abolished in infants with a copper defiency.
This is also indicative of positive (feed forward) effects of
copper on synthesis of this enzyme, and negative (feed back)
effects of the holoenzyme of the biosynthesis of the apoenzyme.
Dekaban et al. (1974) treated four patients with Menkes
syndrome. Case 1 and 2 are the ones they reported in December
of 1974. They treated both MKHD patients with subcutaneous
injection of copper sulfate. They developed a method for
subcutaneous infusion of 1-2 mg of copper sulfate in 25-50 ml
of saline (0.4 mg per ml) given by slow infusion or slow drip
over 2 hrs. The clinical response of Case 1 was as they
reported, moderately encouraging. The progression of mental
deterioration was at least temporarily arrested, there was a
slight improvement in motor performance and the hair became
darker and less friable. Case 2 had spastic diplegia, seizures
and severe retardation. Thus, copper therapy for Case 2 was
of no value. They concluded that it is particularly important
in families in which there was a prior victim of MKHD, other
victims of MKHD be promptly diagnosed and treated in the early
neonatal stage.
Garnica et al. (1977) suggested a different pathogenetic
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mechanism as the underlying cause of MKHD. The hypothesis that
they favor is an abnormality of metallothionein. Metallothio-
nein is a duodenal, renal and hepatic intracellular transport
and storage protein (Dekaban, 1974; Sternlieb, 1973). This
hypothesis is supported by studies in animals and humans
implicating metallothionen in copper storage and absorption
(Van Campen, 1970; Starcher, 1969). Starcher's observations
of the competition between copper and zinc for a presumed
duodenal transport protein suggest that this protein might
mediate absorption of both elements (Starcher, 1969). The
molecular weight of this substance approximates that of metallo¬
thionein. Previous hypotheses or the one presented here could
be explained by intestinal malabsorption of copper, inadequate
hepatic storage and utilization, hypocupremia, and a defect
in metallothionein. One would predict a possible increase in
amniotic fluid copper levels due to elevated fetal urinary
copper excretion. Prenatal diagnosis of Menkes syndrome
should therefore be attempted on this basis.
In 1975 Lott et al. investigated the copper metabolism
in an 11 month old male with MKHD (Lott, 1975a). Serum copper
was 15 ug per 100 ml and seriim ceruloplasmin was undetected.
Less than 1 % of orally administered Cu was absorbed. This
patient was given supplemental copper as cupric sulfate in
two divided doses totalling 0.52 mg per kilogram per day.
Within seven days of such supplemental oral copper the serum
copper rose three-fold (to 45 ug per 100 ml) and remained at
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approximately 75% of the normal concentration for the remain¬
ing 22 days of therapy. After the end of supplementation, the
serum copper returned to baseline in about ten days. It was
concluded that the copper absorption block is only partial in
the steely-hair syndrome and is overcome by high doses of
oral supplements. But we ask if so, why then the return to
baseline after oral supplements?
Lott et al. (1975b) suggests that defect in relative
absorption of copper may result from an abnormal complexing
of copper within the intestinal mucosa. When copper is
finally released into blood stream, an abnormal complex
appears associated with albumin and fails to stimulate cerulo¬
plasmin biosynthesis. They surmised that the potential thera¬
peutic importance was the finding that persistent high doses
of oral Cu may eventually by pass the block with resultant
normal synthesis of ceruloplasmin.
The therapeutic effects of parenteral copper administra¬
tion have been disappointing (Danks, 1974; Bucknall, 1973).
Ceruloplasmin levels can be restored to normal and liver copper
can be replenished. However, no symptomatic improvement has
occurred in patients who were over three months of age at the
start of treatment.
A better result in a baby whose treatment was started at
three days of age was reported by Grover and Scrutton, 1975.
Intravenous infusion of cupric salts was studied in two patients
(cousins). The intravenous doses of copper were gradually
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increased and normal or near normal serum values were achieved
after ‘150 yg of Cu per kg of body weight was administered
once daily for 5 days. At that time the hepatic concentration
of copper in the two patients increased from 14 to 38 yg per
gram of dry weight and from 7 to 45 yg per gram of dry weight
respectively. Continued infusion of cupric salts in doses of
190-220 yg/kg per day once or twice weekly were necessary to
maintain elevated hepatic and serum concentrations of copper.
At 6 months of age the younger infant had reached a function¬
ing level of 4 months. The older infant demonstrated progressive
loss of neurologic functions and died at 15 months of age.
The abnormal hair and the low hepatic copper concentra¬
tion measured to 3 weeks^of age suggested that inadequate
copper was stored in fetal tissue during the latter part of
gestation. They did not find any published information on
spontaneous improvement with copper therapy. They concluded
that their data suggests that early diagnosis by determining
tissue and serum concentrations of copper, and early institu¬
tion of therapy to produce rapid elevation of these concentra¬
tions to values within the normal range may influence favorably
the progressive neurologic dysfunction in trichopoliodystrophy.
In February of 1976 Goka et al., reported the discovery
of a genetic marker in cultured skin fibroblast from patients
diagnosed with Menkes disease. Their results consistently
showed elevated intracellular concentrations of copper in skin
fibroblasts cultured from patients with Menkes disease. This
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elevation in copper concentration set them apart from control
subjects that were presumed heterozygotes. Furthermore, these
findings of elevated copper concentration on Menkes cultures
as a result of the genetic abnormality are consistent with the
reports of Danks et al. (1973a, 1973b). These observations
led them to the conclusion that the increased copper content
of Menkes cells was characteristic of Menkes disease, resulting
from the expression of the genetic abnormality. Thus, this
provides a genetic marker that should prove valuable in both
the diagnosis of Menkes disease and perhaps early detection of
Menkes disease. Furthermore, since it is logical that fetal
cells cultured from individuals with Menkes disease would
express the genetic anomally as increased copper concentrations
in Menkes cultures.
In December of 1976 Oakes reported the first ultrastructu-
ral study of the thoracic aorta and dermis of an 18 month old
body with Menkes syndrome (Williams, 1977). This boy had been
treated in the year prior to death with intravenous copper.
Light microscopy revealed an absence of distinct elastic laminae
in the inner third of the media, but irregular clumps were
present. In the middle and outer media the elastic laminae was
fragmented and discontinuous. The smooth muscle cells that
are normally present between elastic lamellar were replaced
by sparsely distributed cells with irregular outlines. In many
of these cells large irregular accumulations of matachromatic
material were seen within the cytoplasm. Also observed was an
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abnormally large amount of collagen dispersed in large wavy
bundles throughout the wall of the aorta.
Ultrastructurally, the elastin present was electron-
dense and surrounded by a prominent sheath of microfibrils
approximately 100A in diameter. A similar observation was
made for skin elastic fibers. The cells of the middle and
outer thirds of the aortic wall contained myofilaments dis¬
placed peripherally by large aggregates of flocculent material.
Skin fibroblasts did not contain such aggregates.
They surmised that the abnormal elastic fibers observed
in this child could be explained on the basis of a copper
deficiency occurring very early in life, perhaps even in
utero. The abnormally large amount of collagen present through¬
out the aortic wall and the sparse cell population with large
cytoplasmic accumulation of metachromatic material are features
not previously described. The collagen probably indicates
a generalized repair response and may in part account for
the sparse cell numbers because of its abundance. However,
the nature of the large intracellular aggregates and their
relationships to copper deficiency has not been reported.
In July of 1977, Williams reported his findings dealing
with copper therapy in MKHD. In brief, he treated a patient
with Menkes' Kinky-Hair Syndrome with oral CuSO^. The results
were plasma copper, ceruloplasmin, red cell copper, and 24 hour
urine copper excretion remain essentially unchanged. Intra¬
venous copper infusion resulted in a rise of serum ceruloplasmin.
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During the administration of a test meal of *‘*Cu(N03)2, the
patient was given alternately a volume of 0.9% Nad or an
equal volume of plasma intravenously. Radioactivity that was
found in the blood was unchanged after each infusion period.
During 427 days of subcutaneous copper, plasma p-phenylenedia-
mine oxidase activity and plasma copper rose toward normal.
Their subsequent balance studies showed that the patient was
in negative copper balance because of large losses in feces.
Scanning electron microscopy also demonstrated persistent
pili torti. Therefore, they speculated that Menkes' Kinky
Hair Syndrome is probably due to a generalized defect in copper
binding protein that results in increased gastrointestinal
copper loss and persistent abnormalities of hair in the copper-
depleted patient. This should have read malabsorption and
thus poor copper alimentation.
In August of 1977, Garnica et al., reported their
findings after treating a patient with Menkes' Kinky Hair
Syndrome. They treated a 4-month old male, with severe neuro¬
logic disease. He was treated with a 3-week course of intra¬
venous cupric acetate. This treatment had to be discontinued
because the infant developed aminoaciduria. Despite transient
increase in serum copper and ceruloplasmin, there was no
change in the progressive CNS deterioration which characterizes
this condition, and, too, the portion of administered copper
excreted in the urine was excessive. Neither serum amine
oxidase nor leukocyte cytochrome oxidase activity varied in a
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reversibility of the disease seems quite specific and must be
addressed in the human disorder (MKHD).
Camakaris et al. (1979) documented the copper content
of various organs of brindled female heterozygotes and male
mice affected by this X-linked disease. The isotopic ®‘*Cu
was used to study the distribution of copper in these mice.
Their results showed that, the mutation produces abnormal
accumulation or copper in kidney, in gut mucosa and in testis,
but liver, brain, plasma and most other organs showed diminished
copper concentrations. These findings also indicated defective
placental transfer of copper utero, and a marked defect in
intestinal absorption of copper after birth. In addition, it
was shown by these same investigators that there is an abnormal
distribution of copper among the tissues of mice once it is
6 4
absorbed. It was concluded after examining Cu distribution
on the last day of intrauterine development, at 1 day after
birth and at 11 days of age, their findings are in accordance
with a hypothesis that the basic defect involves accumulation
and retention of copper in the cells of affected tissues such
as kidney, gut mucosa and placenta.
Copper therapy of brindled mouse mutants was reported by
Mann et al. (1979). In their experiments, the methods of
treatment was a single subcutaneous injection of 50 ug of
copper at 7 days of age. At 3 days after injection, copper
concentration in previously deficient mutant organs apart from
liver were at least as much as those of treated normals, which
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had remained unchanged. Copper in mutant livers increased
only slightly in comparison to normal controls. A state of
copper deficiency recurred in mutant tissues by 25 days after
injection. Alkylpolyether and sebacic acid treatments resulted
in greater growth rates than cuprous and cupric solution. It
was concluded that the greater growth rates may have been due
to a delayed release of copper from the site of the injection.
Mann et al. (1979b), reported that there was a defective
placental transfer of ®‘*Cu to fetal brindie mice. They ob-
served in pregnant Mo female mice that copper distribution
to fetuses was impaired. The results of these experiments
indicated an impairment of placental transfer of copper into
both the Mo^^ female and Mo^^ male fetuses. This disturbance
was suggested by Mann to be due to the consequence of fetal
contribution to the placenta, because the maternal (Mo^^ fe¬
male) contribution would be the same for all genotypes. It
was presumed that the endothelial cells of the capillaries of
the placenta shows a disturbance of copper transport similar
br*
to that seen in the mucosal cells of the gut of postnatal Mo
male mice (Evans and Reis, 1978).
The genetic lesions in both man and mouse establishes the
existence of a specific transport system for copper. It is,
also possible, as in the case of the mottled locus in mice,
that multiple alleles at the Kinky Hair Syndrome (KHS) locus
exist in man. The studies summarized here suggest some of the
known defects in utilization of dietary copper in man. Several
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All electrophoresis equipment and supplies were pur¬
chased from Bio-Rad Laboratories. Copper reference solutions
were purchased from Fisher Scientific Co.. Female mice hetero-
bx"
zygous for Mo were obtained from Argonne National Laboratories.
Normal Black Agouti mice were obtained from a previous stock
already maintained in this laboratory. All other chemicals
and regents were purchased from Fisher Scientific Co. except
for the Bathocuprione which was purchased from Sigma Chemical
Company.
Animal Care and Diets
Adult mice were maintained on Mouse Chow pellets from
Ralston Purina Company. Regular tap water was used for drink-
king. All mice were housed in individual plastic cages with
wood shavings as bedding. All cages were cleaned at least
once weekly.
In these experiments a total of about 200 heterozygous
females and 200 normal females were maintained on regular
mouse chow and tap water. At birth all pups were counted and
the number of each kind of pup as well as the total number of
pups was recorded per litter. Starting with the fifth day
all pups were killed by decapitation for analysis.
In a second set of experiments 12 normal and 12 hetero-
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zygous (Mo^^) females were used. These animals were fed a
high copper diet (500 mg per gram of chow) prior to insemina¬
tion and were maintained on this diet. The mature partners
were normal males from the Black Agouti stock and the females
were from the Mo^^ stock maintained in this laboratory. Blood
copper levels were monitored three times each week. The
number and type (phenotype) of each litter was recorded. The
pups were sacrificed by decapitation and their intestinal cell
membrane proteins evaluated by electrophoresis.
Tissue Preparation
The upper 9 cm of the small intestine was removed,
inverted over a small glass rod, and washed gently with 0.9%
MST (0.3% Mannitol, 0.3% Sucrose, 0.3% Tris). After all of
the partially digested milk was removed the remaining cells
(fluffy white coat) were shaken off in 0.9% MST. These cells
were centrifuged for 3 minutes at 1,500 rpms. The supernatant
was disgarded and the pellet was resuspended in ice cold
deionized water. Lysis was allowed to occur by letting the
mixture stand for 45 minutes at 4°C.
Next, this suspension was centrifuged for 3 minutes at
1,500 rpms. The pellet from this spin contained the cell
membranes and the supernatant contained the cytosol of these
cells. The supernatant was removed and stored at -25*^C or
used immediately in the copper binding analysis. The pellet
was washed, resuspended in 5 volumes of deionized water, and
centrifuged at 1,500 rpms for five minutes. This step was
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repeated 10 times to insure purity of the membranes. After
the fifth wash the pellet was resuspended in 3 volumes of
deionized water, frozen, and lyophilized. The lyophilization
was done overnight and the samples were stored at -25°C. The
membrane samples were more readily solubilized by SDS (sodium
dodecyl sulfate) when they were first lyophilized.
Disc Gel Electrophoresis Technique
This procedure is a slight modification of the SDS-gel
electrophoresis system of Weber and Osborn (1969).
Preparation of Membrane Samples
Membrane samples for SDS gel electrophoresis were pre¬
pared by adding 1 mg of lymphilized membrane material, 5 ul
of B-mercaptoethanol and 50 ul of 10% SDS to a small vial with
a screw cap. Each membrane sample was placed in a boiling
water bath for 5 minutes. SDS (1.5 mg) was then added to
each vial and each vial was heated for another 5 minutes or
until all the membrane material had dissolved. The dissolved
samples were allowed to cool and 50 yl of 0.002% bromophenol
blue in 50% glycerol was added to each sample to serve as a
tracking dye.
Preparation of Gels
The gel buffer contained 7.8 grams of NaH2PO^•H20, 38.6
grams of Na2HP04.7H20, 2 grams of SDS per liter of solution.
For the 22% acrylamide solution 22.2 grams of acrylamide and
0.5 grams of methylene bis acrylamide were dissolved in water
to yield 100 ml of solution. Insoluble material was removed
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by filtration through Whatman No. 1 filter paper. The solu¬
tion was kept in a dark brown bottle at 4°C in the dark.
The glass gel tubes were 12.5 cm in length with an
inner diameter of 5 mm. Before use they were soaked in DDW
(distilled deionized water), rinsed and oven-dried. 0.5 cm
was marked off at one end of each tube and they were placed
in a gel tube holder.
Tubes were filled to the 0.5 cm mark with 0.85 M sucrose
(approximately 0.1 ml). The sucrose was eventually shaken out
of the tubes and replaced by the gel containing the protein
sample. This is the top of the gel nearest the cathode.
Spacer gel which is a 3% acrylamide gel consisted of the
following:
1. 1 ml of 30% acrylamide with 0.8% bis-acrylamide.
2. 1.25 ml of 1.5 M tris HCl pH 8.8
3. 0.10 ml of 10% sodium dodecyl sulfate.
4. 5 ul of TEMED.
5. 0.1 ml of 10% ammonium persulfate.
6. total volume adjusted to 9.9 ml with DDW.
The sample and spacer gels are less concentrated (large
pore size), have a lower ionic strength and are at a lower
pH in order to allow the sample components to move rapidly
to the separation gel boundry and then more slowly through
the separation gel. This sharpens the sample to a thickness
of less than 2 mm and produces sharper, better separated bands.
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Sodium lauryl sulfate or sodium dodecyl sulfate (SDS)
is used in the sample, spacer gel, separation gel and the
buffer system to insure continued solubilization of the sample
while electrophoresis proceeds.N,N,N,N-tetramethylenediamide (TEMED), is the catalyst
which provides the free radical that enables polymerization
of monomer acrylamide and bis-acrylamide to occur. Free
oxygen radicals are produced from the persulfate by TEMED in
sufficient quantity to transform monomer to the free radical
state to initiate polymerization. Concentrations of TEMED and
ammonium persulfate were determined and the one that resulted
in gelation in 10 to 30 minutes was used.O.3 ml of spacer gel was added on top of the sucrose
layer. This was done slowly enough to avoid mixing with the
sucrose. Then on overlay (0.1 cm) of water was immediately
placed on the polymerizing gel to insure a flat surface at the
interface. This water layer was removed before the separation
gel was added.
The separation gel was made up of the following mixture;
1. 6.3 ml of water.
2. 14 ml of buffer (gel buffer).
3. 6.3 ml of a 22% acryalmide solution.
4. 1.4 ml of ammonium persulfate solution (15 mg/ml).
5. 25 yg of TEMED.
After mixing each tube was filled with this solution. Before
the gel hardened a few drops of water was layered on top of
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the gel solution. After 10 to 20 minutes an interface could
be seen indicating that the gel had solidified. Just before
use the water layer was removed and the tubes were placed in
the electrophoresis chamber. The bottom compartment of the
electrophoresis apparatus was filled with gel-buffer that was
undiluted.
After the separation gel was allowed to polymerize for
about 30 minutes, the gel tubes were removed from their gel
stand and the 0.85 M sucrose was shaken out. The gels were
inserted into the grommets in the top reservoir chamber and
gel buffer undiluted was added. If there were bubbles under
the separation gel surface, they were removed by shaking the
tube or by using a curved tip Pasteur pipette to suck the
bubble away. The sample preparation in 0.025 ml was then
placed on top of the spacer gel, and electrophoresis begun.
Electrophoresis lasted for about 8 hours at 200 mA and was
stopped when the tracking dye reached the bottom of the sepa¬
ration gel.
Ultrafiltration
The ultrafiltration procedure at first described by
Moore (1964), served to concentrate the sample before electro¬
phoresis and equilibrium dialysis were attempted. Dialysis
tubing was cut to a desired length depending on the amount of
sample to be concentrated and soaked in a 10 mM solution of
EDTA (Ethylene-diamine-tetra-acetic Acid) pH 7.4 for 10 minutes
making sure that the inside of the tubing was washed thoroughly
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The tubing was then washed thoroughly in DDW at least
3 times, tied at one end and left in a beaker of DDW before
use. The open end of the bag was stretched and pushed onto
the end of a separatory funnel on which a rubber stopper of
specific diameter was already fitted. The bag was then tied
several times with silk or cotton thread, to make sure that the
dialysis bag would not come off when subjected to vacuum pre¬
ssure. Horizontal grooves were pressed into the sides of the
end tube of the separatory funnel (with a hot file or other
piece, of metal) before the dialysis bag was put in place. The
cotton thread could then be tied in the grooves to insure
against slippage and leaks. The crude cytoplasm was then
poured into the separatory funnel which lead into the dialysis
bag. Previously a vacuum erlenmyer flask fitted with a column
which was about 5 cm longer than the dialysis bag was placed
in the cold room (0-5°C). Upon completion the cytoplasm sample
was washed from the bag with cold DDW to the desired concentra¬
tion.
Equilibrium Dialysis
This procedure was performed in order to affirm which of
the three cellular fractions would bind the largest amount of
copper. A sample of each of the cellular fractions was placed
in separate washed (10 iiiM EDTA pH 7.4 and DDW) dialysis bags. ,
The bags were placed in separate vials containing a solution of
copper (2.5 yg/ml). Magnetic stirring bars were added for mix¬
ing. The dialysis was allowed to continue for 5 hours in the
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cold room (0-5°C). Afterwards, a sample from both inside
and outside of each bag was taken for copper determination.
Copper Staining of Polyacrylamide Gels
Polyacrylamide gels were stained by the method of Bruy-
nincky et al. (1978). This method is based upon the quenching
1 +
of the fluorescence of bathocuproine sulfate by Cu . This
test is one to two orders of magnitude more sensitive than
previously described tests and is specific with respect to
3+ 2 +
interference by Fe , Mn , or heme. The method listed below
is unmodified.
The gels were stained immediately after removal from the
electrophoresis apparatus.
1. The gels were first soaked for one minute in
16 itiM ascorbate in 10% glacial acetic acid to
denature proteins and to reduce the metal ions.
2. Next, the gels were soaked for one minute in a
0.28 mM aqueous bathocuproine sulfonate solution.
3. Staining pattern on the gels was observed under
UV light or scanned with a spectrophotometer
(Beckman Model 35) equipped with a recorder.
After staining with bathocuproine sulfonate and band F
located (Results Section), the kinetics of this protein was
recorded. First it was recorded in the presence of 50 ul of
CuSO^ , that had been added to the reaction medium. Secondly,
in the presence of 50 ul of ZnClg (0.1 M) and 50 ul of CuSO^
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(0.1 M). Thirdly, in the presence of 50 ul of CuSO^ and 50
ul of Cd (0.1 M CdCla).
Slab Gel Electrophoresis Technique
This technique is a modified method of Laemmli (1970).
Gels containing 7.2% stacking and 10% separation gels were pre¬
pared from a stock solution of 30% by weight acrylamide and
0.8% by weight of N,N'-bis-methylene acrylamide. The final
concentrations in the separation gel were as follows; 0.375%
Tris HCl (pH 8.8) and 0.1% SDS. The gels were polymerized
chemically by the addition of 0.025% by volume of tetramethyl-
ethlenediamine (TEMED) and ammonium persulfhate. The stacking
gels of 7.2% acrylamide and a length of 1 cm contained 0.125 M
Tris-HCl (pH 6.8) and 0.1% SDS were polymerized chemically in
the same way as the separation gel. The electrode buffer
(pH 8.3) contained 0.025 M Tris and 0.19 M glycine and 0.1%
SDS. The sample (0.025 ml - 0.050 ml) contained the final
concentrations (final sample buffer) 0.0625 M Tris-HCl (pH 6.8),
2.0% SDS, 10% glycerol, 5.0% 2-mercaptoethanol and 0.001%
bromophenol blue as the tracking dye. The proteins were com¬
pletely dissociated by immersing the samples for 5 minutes in
boiling water and then adding one milligram of SDS and heating
again in boiling water until the membranes dissolved (approxi¬
mately 15 minutes).
Electrophoresis was carried out with a current of 3 mA per
gel until the bromophenol blue marker reached the bottom of
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the gel (about 24 hours). The gels were stained overnight at
26°C with a 0.25% Coomassie Brilliant blue solution. The gels
were diffusion-destained by repeated washing in a solution of
10% acetic acid and 10% iso-propanol.
Preparation and Preservation of Serum
Freshly drawn whole blood was allowed to stand for several
hours, during which time the fibrinogen changes to a fibrin
gel (clot). This clot slowly contracts and expresses out the
fluid or serum portion of the blood. After the cellular
elements were removed calcium was added to facilitate removal
of residual fibrinogen as fibrin which was then removed by
centrifugation. Although the concentration of fibrinogen was
small (0.3%) it is relatively unstable and constituted an un¬
desirable factor for the serological analyses (Ouchterlony
Tests) to follow.
Sterile techniques were usually required in the follow¬
ing procedure to eliminate the possibility of gross contamina¬
tion and, the need for a high concentration of antibiotics.
The procedure that follows was taken from Methods in Immuno¬
logy (1970) and adapted for our needs.
Procedure
1. The freshly drawn blood was allowed to stand
for 1 to 2 hours at room temperature for clot
formation. Later, the clot was carefully
separated from the wall of the tube with a
steel spatula. The blood was stored in a
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refrigerator for 12 to 24 hours to permit
clot contraction.
2. The serum was decanted in clean tubes and centri¬
fuged at 1,000 X g for 30 minutes at 4°C (250 rpms).
The serum was carefully removed with a pipette.
3. Since it was always desirable to have very clear
serum and often the serum from the first centri¬
fugation contained a few erythrocytes or white
cells, these cells were removed by repeated centri¬
fugation as described above.
4. When the serum was to be stored for more than 5
days it was sterilized by filtration, and stored
at -70°C.
Procedure for Preparation of Diffusion Plates
1 . Agar was added to the borate-saline solution in
an erlenmyer flask, soaked for a few minutes to
facilitate solubilizing, and then it was com¬
pletely dissolved by heating the flask in a
beaker of boiling water. To the melted agar
was added Merthiolate and Trypan Blue solution.
The pH was checked to insure that it was 7.8 to
8.0.
Eight militers of very hot agar solution were
rapidly pipetted into the bottom section of
each of four petri dishes. The agar was kept
2.
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melted by returning the flask to a beaker of
hot water. Special care was taken to make sure
no appreciable water loss resulted from
excessive heating.
3. The plates were allowed to stand for 30 minutes
to permit solidification of the agar.
4. Pattern "A" (Methods in Immunology/ 1970) was
placed beneath all four petri dishes prepared
in steps 2 and 3 above.
5. The pencylinders was positioned according to
pattern "A" and 8 ml of hot agar was pipetted
into the dishes to form the top agar layer.
This procedure was repeated, preparing a total
of four such plates.
6. The unused agar was pipetted in 8 ml amounts
into separate test tubes and stored under
refrigeration.
7. The plates of agar were left to solidify at least
one hour before used.
Procedure for Performance of Tests in Plates
1. The cylinders were removed from the agar plates
and 0.1 ml of sample was added to the wells.
Condensation on the surface of the agar was
prevented by placing a piece of filter paper in
the lid of each plate prior to incubation.
2.
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(The filter paper was cut slightly larger
than the lid in order to effect a tight fit).
3. The plates were placed in a humidified 37°C
incubator for development of precipitin lines.
4. The plates were observed daily for about a week.
This was a sufficient period of incubation to
allow observation of the precipitin reactions
in all four plates.
Study of Plates
1 . Rabbit antimembrane protein serum was placed in
the center well of each plate.
2. The antigen samples (isolated protein bands from
gel electrophoresis) were placed in the circum¬
ferential wells with duplicates in adjacent
wells.
3. Precipitation was allowed to develop by testing
the plates as stated earlier.
4. The formation of bands was observed over a period
of 7 to 21 days.
Insitu Testing of the Antiserum
10 ul of antiserum developed against band F protein was
injected intravenously into adult Black Agouti male mice
(previously starved for 36 hours). After the injection they
were put on a high copper diet (500 mg per gram of mouse
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chow). Blood copper was measured each hour after the food
was administered, and continued for 5 hours.
Copper Analysis
Total copper analysis of the blood was carried out as
follows: 3 ml of blood was placed in 1 ml of deionized
water, and the mixture was evaluated for its copper content
using the atomic absorption spectrophometer (Perkin Elmer
Model 107). Tissue samples were first ashed in ultra pure
nitric acid, diluted to 2 ml with deionized water and the
copper content determined. To avoid copper contamination,
all glassware used in this study was soaked in HNOy for 24
hours and rinsed in distilled deionized water.
CHAPTER IV
RESULTS
Behavioral and Growth Effects
Parental copper therapy in both the normal and hetero¬
zygous female led to the survival of only a very few off¬
spring. The surviving offsprings included only normal and
heterozygous females. The copper fed mothers became very
sluggish and also very canabalistic. AS their blood copper
levels approached 100% of normal these symptoms became more
evident and too, several would die close to term or during
the early postpartem period. It was also noted that as
blood copper rose above normal there were fewer offsprings
born to any female. The few that were born were usually
eaten by the mother.
Subcutaneous copper therapy was administered to male
(Mo^^) offsprings and when they were treated according to
the schedule in Table 1, they did survive. In contrast,
untreated pups did not survive beyond 14 days.
Idit
Mo males were not significantly smaller than their
normal littermates at birth. Mo^^ males weighed at age 3
days 2.0 g ± 0.8 g and normal littermates weighed 2.2 g +
0.1 g. A normal weight increase was noted for all offsprings
until about 10 days after birth. After this time Mo^^ males
started to lose weight and died on the 14th or 15th day as
shown in Fig. 1. As the Mo^^ males approached death there
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Table 1 . Schema of copper injection in normal (Norm) and
Hemizygous (Mo^^) male littermates. *
Age in Days
Treated Treated
Norm Mo^^ Norm MO
ul of 0.1 M CuSO**
3 1 .0 1 .0 0.0 0.0
5 1.0 1.0 0.0 0.0
7 1 .0 1 .0 0.0 o•o
11 1.0 1.0 0.0 0.0
13 1 .0 1 .0 0.0 o•o
1 7 2.0 2.0 0.0 Death
21 2.0 2.0 0.0
25 2.0 2.0 0.0
28 2.0 2.0 0.0
* The days of injection coincide with the age of the
animals. These animals were examined at different
times for blood copper, tissue copper, and for
specific enzymes as stated elsewhere.
Fig. 1 :
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Growth curve for untreated Mo males (0) and




were periods of general inactivity, and sporadic periods of
intense seizure.
Mo^^ males that were treated had a very different in¬
flection of growth at 12 days (Fig. 2). They had attained
about 75% to 85% of the weight of their normal littermates
at 21 days of age. At 28 days of age, the Mo^^ males usually
had attained at least 95% of the weight of the normal litter¬
mates. At adulthood there was no observable difference between
IdIT
the general activity of treated Mo males and its littermates.
The only observable difference was in coat color, (Figs. 3, 4,
5, 6, 7) .
Equilibrium Dialysis and Copper Binding
The results of the copper binding assay determined by
equilibrium dialysis are shown in Fig. 8. Intestinal cell
membrane bound copper over 30% more than any other cellular
fraction. Water was used as the control. At the end of the
dialysis, half of the copper was inside the dialysis bag and
half of the copper was in the solution surrounding the dialy¬
sis bag. Those experimental samples (membrane, cytoplasm,
microsomal) that bound copper, their copper concentrations
were higher than the control dialysis bag. Also those samples
that bound copper had a copper concentration that was higher
on the inside of the dialysis bag than on the outside. The
assay revealed that membrane bound 30% more copper than the
control, while cytoplasm bound only 5% more and the microso¬
mal fraction did not bind any copper at all or at least any
Fig. 2:
b'
Growth curve for copper treated Mo





br male 14 days old, untreated.Fig. 3:
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Fig. 4: Normal adult male.
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Fig. 5: Adult male that received copper therapy.
51
Fig. 6: Adult heterozygous female.
 
Fig. 7; Normal adult female.
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Fig. 8: Copper binding ability of water ) and the
cellular fractions, membrane (Ijij:) » cytoplasm
(S), and microsomal (|). The results are
expressed as percent of total copper that was





























Electrophoresis of Solubilized Intestinal Cell
Membrane Protein
Tube gel electrophoresis of intestinal cell membrane
protein (ICMP), demonstrated a very specific difference
between the untreated Mo^^ males, Mo^^ females, treated Mo^^
males and normal litterraates. The results are shown in Fig.
9, and Table 2. The gels were compared on the basis of
protein bands presence or absence. Only one band was absent
br
from the Mo male sample and was present in all other sam¬
ples. That band is band "F" in Fig. 9.
The tube gels were further evaluated for alteration in
protein banding patterns. The different gels that were
scanned are shown in Fig. 10 and 11. The corresponding scan
of each gel is shown in Figures 12, 13, 14, 15. It can be
seen in graphs resulting from the scan, that the center peak
(band F) from the Mo male samples when compared to normal
and Mo“^ females samples graphs as absent.
In order to determine which band contained the most
copper each gel was copper stained as described in the Methods
Section. It was found that all the protein bands had a posi¬
tive reaction in the copper test. But band F was not only
positive but bound the copper stain at a constant rate. That
data is shown in Fig. 16. Also when copper was added to the
gel containing band F, and band F was observed at 280 nM, the
results showed that band F would exhibit a characteristic
Fig. 9; Shown are the results of the disc gel electro¬
phoresis. The gels are labeled from top to
bottom (A-H) and from left to right (1-8).
Gels; (1-4) Mo^^ male, (5) normal male, (6)
blT
normal male copper treated, (7) Mo female,
(8) Mo^^ male copper treated.
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Table 2. The comparison of disc gel electrophoresed protein
bands based on their presence (0) and absence (X) .
Samples * A B C D E F G H
1 0 0 ' 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0
3 0 0 0 0 0 X 0 0
4 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0
* {1) Normal male , (2) normal male that received
copper therapy, (3) Mo^^ male, (4) Mo male that
received copper therapy, (5)
br
MO female.
Fig. 10: Disc gels that were scanned with a spectrophoto¬
meter for further evaluation. Gel; (1) normal
male, (2) normal male copper treated, (3) Mo^^
female, (4) Mo^^ male copper treated.
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1 2 3 4
Fig. 11: Disc gels that were scanned with a spectrophoto¬
meter for further evaluation. Gel; (1) Mo^^ male,
one mouse, (2) Mo^^ male, pooled two mice, (3) Mo^^
male, pooled five mice, (4) Mo^^ male, pooled ten
mice.
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1 2 3 4
Fig. 12A; Scan of gel number one {normal male) in Figure
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Scan of gel number one (normal male) after
staining with coomassie blue (solid line), and
after staining for copper (dotted line). Band














Fig. 13; Scan of gel number one (Mo^^ male) in Figure
11. The Band F position is indicated by the
arrow.
Distance in cm-
Fig. 14: Scan of gel number four (Mo^^ copper ^treated)
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Fig. 15 Scan of gel number three (MO
br female) in Figure
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Fig. 16; Kinetic curve of Band F without any copper,
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alternating increase and decrease of O.D. with time (Fig. 17).
Under these conditions no other protein exhibited this trait.
This constant rate was also evaluated in the presence of
Zn a known competitor of Cu binding (Fig. 18), and in the
presence of cadmium a known inhibitor of copper binding
(Fig. 19).
Scanning the gels of ICMP sanples derived from Mo^^ males
did not reveal any protein at the band F position even when
the gels were scanned at maximum sensitivity (0.01 O.D. full
scale), (Figs. 20, 21).
The results of the slab gel electrophoresis are shown in
Fig. 22. The major bands are labeled and Table 3 was con¬
structed to compare the presence and absence of the various
protein bands. At first glance the results from the slab
gel electrophoresis were more striking than the tube gel
electrophoresis results. Referring to Table 3, band DI is
totally missing from untreated Mo^^ male mice. Also at the
same time there was an increase in band C IV (Fig. 22). Band
C III was only present in Mo^^ untreated males and at a
lesser concentration in treated males. Only in untreated
Mo^^ maled did band A III show consistant splitting.
Immunodiffusion Tests
The results of the immunodiffusion test are shown in Table
4. The antibody used in this test was developed against band
F protein (tube gel). When antibodies against band F protein
Fig. 17: Kinetic curve of Band F in the presence of
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Fig. 18: Kinetic curve of Band F in the presence of
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Fig. 19: Kinetic curve of Band F in the presence of
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Fig. 20: Scan of gel number one (Mo^^ male)
sensitivity (0.01 O.D. full scale)








Fig. 21: Scan of gel number one (Mo male) at maximum
sensitivity (0.01 O.D. full scale). Band F
position is indicated by the arrow. Gel was
stained for copper before it was scanned.
Distance in cm.
 
Fig. 22: Shown are the results of the slab gel electro¬
phoresis. The gels are labeled from top to
bottom (A-D) and from left to right (1-20).
Gel; (1-3) normal, (4) blank, (5-8) Mo^^ male,
(9-12) Mo^^ male copper treated, (13-16) Mo^^
female, (17-20) normal male.









la, Ib la, Ib la, Ib, Ic +Ia, Ib
Ila, lib Ila, Ilb Ila, lib
Ila
+IIIa, mb +IIIa +IIIa, Illb Ilia, mb
IIIc
IVa, IVb IVa, IVb IVa, IVb
IVa
+ Bands that are considered to be most important.
MW: Molecular Weight
Table 4. Results of Ouchterlony test when Band F protein antiserum was used in the







1 X 0 X X
2 0 0 0 0
3 0 0 0 0
4 0 0 0 0
5 0 0 t) 0
* (1) Intestinal cells, (2) liver homogenate, (3) brain homogenate,




were used as a probe to search for band F protein in other
cellular fractions, it was found to be present only in intes¬
tinal cell membranes of normal Mo^^ female and Cu treated Mo^^
male mice.
We checked intestinal, liver, brain, muscle, and blood
cells. Some of the actual positive and negative tests are
shown in Figs. 23, 24 and 25.
Insitu Test of Antiserum
In situ testing of the antiserum demonstrated, that the
antibodies present in the antiserum could block the uptake
of copper from the diet of normal Black Agouti mice. Once the
antiserum was administered to normal adult mice we monitored
their blood copper levels (Fig. 26) . Blood copper levels con¬
tinued to rise to a maximum in animals that did not receive
an injection of the antiserum. But in those that did receive
an injection of antiserum, blood copper levels rose only
slightly during the same period of time.
Fig. 23: Shown is an actual immunodiffusion plate that is
positive. Center well contained whole undigested
membrane protein. Outer wells contained Band F
protein antiserum.
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Fig. 24: Shown are actual positive tests from intestinal
membrane protein extracted from (a) normal male,
(b) Mo^^ female, (c) Mo^^ male copper treated. The
antiserum was placed in wells (d) and (e). Wells
(f), (g) and (h) contained intestinal cell membrane
protein extracted from three different Mo^^ males.
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Fig. 25: Shown is an actual iimnunodiffusion plate that
is negative. The center well contained B and
F antiserum. Outerwalls contained (a) brain,
(b) liver, (c) muscel, (d) blood, (e) intesti-
nal cell homogenate from Mo males, (f) water.
78
Fig. 26: Shown are the results of in situ testion of
Band F protein antiserum. Blood cooper was
measured each hour after injection of antiserum
and administering a high copper diet. Control
















Previous studies in our laboratory (Everett and Moore,
1978) and subsequently in the laboratory of Suzuki (1979)
indicated that special copper therapy of neonatal Mo hemi-
zygotes results in normalization of the otherwise diseased
animal.
We questioned the problem of the apparent return to
normal copper absorption after the therapeutic normalization
of the Mo^^ male. As a result of this, the following problems
were addressed. First, is there a special protein (ionophore)
which is located on the serosal side of the IMC which could
be absent from the neonatal hemizygotes. If there were such
a protein, is it restored upon copper treatment and can this
protein be identified by physical means? We also asked, can
we demonstrate by immunochemistry the presence or absence of
such a protein in isolated ICMP fractions? Lastly, we addresse
the question of whether we could develop a specific anti-body
by removal of a protein or proteins which may show up different
in the various ICMP fractions and how can we be sure of the
special identify of any apparently aberrant or missing proteins
in terms of function.
The answers to the first and second questions, 'is there
a special protein which is located on the serosal side of the
IMC which could be absent from the neonatal hemizygotes* and
'could such a protein be restored upon copper treatment.' the
80
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answers to both questions is yes. The support for this answer
is presented in Figures 1 and 2. In Figure 1, only one visible
difference was observed and that was band F which was present
in all other ICMP samples but was never found in untreated
Mo^^ males. When Mo^^ males were treated with copper this
protein at the band F position does appear. This definitely
indicates that the de novo synthesis of band H protein is in
response to copper administration. The same is true for
Figure 2.
When one examines the electrophoretic (Fig. 22) patterns
of the membrane proteins developed on the slab gel/ there are
more obvious differences between the protein preparations from
untreated hemizygous males and their normal littermates.
The bands which are missing from the untreated hemizy-
gote seem to reappear upon copper treatment. There is however
less protein at these loci. This suggests a tendency toward
normalization. An even more striking event occurred when
normal/ Mo^^ heterozygotes/ copper treated Mo^^ males and Mo^’^
males that did not receive copper therapy/ ICMP were electro-
phoresed together. All of the differences noted in untreated
Mo“^ males when compared to normal littermates decreased in
intensity in the different types of mice in the following order
Mo^^ males untreated/ copper treated Mo^^ males/ Mo^^ females
showed slightly more reduction in intensity and normal mice
br
which showed none of the abberations found in untreated MO
males. These findings were highly indicative of the identi¬
fication of a heretofore unrepresented phenotypic (biochemical)
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marker that is related to the genetics of this disease.
The answers to the third and fourth questions that we
asked are no and yes respectively. We have not been able to
match the identity of the band F (disc gel) or band D I (slab
gel) to the identity of any other known protein. The fourth
question of whether we could demonstrate the presence or ab-,
sence of band F protein in isolated ICMP fractions, the answer
to this question is yes. We have found this protein to be
present only in intestinal cell membranes of normal, Mo^^
females and copper treated mlaes and not in any other tissue
tested (Table 4). This is highly suggestive that the defect
in the mottled mouse is localized within the intestine itself,
and since it is probably due to the absence of copper in the
blood, there must be some vascular mucosal cell interaction
which is initiated by the appropriate levels of copper.
The fifth question of whether we could develop a speci¬
fic antibody by removal of protein or proteins which show up
differently in the various ICMP fractions, the answer to this
question is yes and we did. We developed a rabbit antibody
to the band F protein of the tube gel, and used this antibody
in the Ouchterlony iraraunoprecipitin test. The source of anti¬
gen for the test were the various plasma membrane protein and
other proteins from normal, heterozygote Mo female and the
hemizygote Mo^^ (diseased) male. This provided us with an
important tool to support the theory that the primary defect
of MKHD is a localized one (within the gastrointestinal mucosa'
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vascular couple) and not a generalized one (Goka et al., 1976).
As can be seen, band H protein was only found in ICMP fractions
(Table 4).
The last question we addressed ourselves to was, 'how
could we be sure of the special identify of any apparently
aberrant or missing proteins in terms of their function?'
In order to answer this question with affirmation we stained
the disc gels with bathocuproine sulfonate, a stain specific
for copper. It was our belief that the protein responsible
for copper accumulation in the gastrointestinal tract of
mottled mutant mice would bind more copper than any other
protein on the disc gel and thus, lend itself to identification,
This was exactly the case, and this protein was the protein
in the band H position.
Further evaluation of the copper binding activity of
the proteins on the gel revealed that band F underwent some
definitive changes during repetitive desitometric scanning
of the gel. That is, the intesity of the Cu-bathocuproine-
protein complex seemed to increase and decrease alternatively.
This behavior was not evident anywhere else on the gel.
Stationary evaluation of this locus (band F) in the
spectrophotometer showed that there was a continuing change
in the absorbancy. These findings are indicative of slow on
off kinetics of copper binding by band F, and we believe that
this is due to conformational changes brought about by the bind¬
ing and subsequent release of copper now claimed by us to be th<
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copper transport protein of the small intestine.
Since it is known that Zn is a competitive inhibitor of
Cu transport while Cd is a non-competitive inhibitor, we
examined the effect of these two metal ions on the copper
binding characteristics of band H.
Figure 18 shows how Zn alters the on off kinetics of
Cu binding. The regular slow oscillatory patterns seen nor¬
mally are changed to shorter and faster ones. When the rate
was evaluated in the presence of cadmium, copper binding and
with it the on off kinetic rate dropped to zero which is an
example of total inhibition. Based on this set of data we are
sure that we have identified the specific biochemical abnorma¬
lity that is localized within the intestinal mucosa.
The biochemical discovery here is a definite first. We
have identified a protein in the Black Agouti mouse that is
biT
absent in Mo male mice. This protein binds copper, while
embedded in the polyacrylamide gel, and illustrates there, slow
on/off kinetics for this binding process. When zinc is added
to the reaction mixture this reaction (on/off copper binding)
changes to an oscillatory pattern that is faster than it is in
the absence of zinc. To further nail down the identify of this
protein (band F) as a copper binding (copper transport protein)
protein, the Cu binding on the acrylamide gel was conducted in
the presence of Cd. The result was total inhibition of the
activity of this protein.
This contribution to biochemistry is not only of importanc
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to MKHD and an understnading of how copper is transported
across the gastrointestinal mucosa, but also introduces to
biochemistry a technique for looking at membrane proteins
(and probably other proteins) which undergo gross conforms




Hunt (1974) has described variants of the mottled
mutant mouse (Mo) with different degress of abnormality re¬
lative to malabsorption of copper. In 1978 (Everett and
Idtt
Moore) used the Brindled variant (Mo ) of the mottled mutant
mouse to study the problem of copper nutrition, as a model
for Menkes Kinky Hair Disease (MKHD). This X-linked inherited
progressive brain disease is invariably fatal with focal cere¬
bellar and cerebral degeneration, growth retardation and
abnormal hair. Recurrent convulsions are prevalent as the
disease progresses. Addition of 1 to 200 mM copper sulfate
to the drinking water caused a high degree of fatality as did
addition of copper to the mouse chow. Subcutaneously injected
copper did lead to the survival of the Mo^^ males, it was con¬
cluded that, the major implication was the time table of treat¬
ment vs the clinical manifestation of Menkes Kinky Hair Disease
must be addressed in the human disorder.
Until now intrauterine diagnosis seemed likely because
the infant will be receiving adequate copper from his mother.
We have isolated a protein from normal mice that is involved
lD}r
in copper transport. This protein is absent from Mo males
and appears upon subsequent administration of copper. This
protein is present in heterozygous females but at a lower con¬
centration than in normal Black Agouti mice. It is this protein
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that has served as a biochemical marker for identifying the
various types of mice used in these experiments.
The implication of our findings strongly suggests that
intrauterine diagnosis is possible and treatment should begin
prenatally at best, or should be started at least 48 hours
after birth. The therapy should be administered to only those
males born into such families with histories of MKHD and having
a deficiency in band H or band D I proteins. After a relative
short period the infant should be able to absorb copper from
his diet. This hypothesis is supported by the fact that the
biT
Mo males can survive without copper supplementation after
receiving copper therapy for only 4 weeks and too, those pro¬
teins that were found to be absent appear upon subsequent copper
therapy.
The clinical implications as they relate to Menkes Kinky
Hair Disease are as follows:
Our earlier studies indicate that early copper injections
can lead to normalization of the Mo^^ male. The untreated
diseased animal dies before the fourteenth postnatal day, and
the animals were best by extensive seizure activities, weight
loss and failure to thrive. All these symptoms were lost after
the appropriate therapy as outlined. The development of the
murine brain is far from complete at birth and myelination
continues up to and sometimes slightly beyond the fourteenth
postnatal day. The human brain is far more developed at birth
and the chances of corrective anatomically related functional
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neurologic deficits are quite minimal.
In utero copper therapy after prenatal identification of
Menkes disease (in a fetal candidate) becomes a most important
approach to correcting this disorder.
The fact that the Grover baby survived after therapy
was only initiated after several postnatal days had elapsed
indicates that copper therapy in the human does have potential.
The fact is however that babies treated after the 3rd or 35th
day of life either die or survive with continued neurologic
deficits including seizure activity.
Our data becomes important in that it indicates that
prenatal therapy ought to be initiated before massive brain
development had occurred or should have occurred.
The findings that after an appropriate time of intra-
peritoneally injected copper the Mo^^ male can now absorb
copper from his diet would lead one to believe that there is
a gastro“intestinal mucosal vascular axis necessary to the
transport or uptake of copper. The similarity between plasma
calcium homeostasis which is hormonally controlled (pituitary
thyroid hormone, calcitonin, 1,2,5-cholestadiueol) and that of
the plasma copper homeostasis leads us to believe that there
ought to be some hormonal control over the biosynthesis of the
copper transport protein of the upper gastro-intestinal
tract.
After short term copper therapy was terminated prior to
postnatal day fourteen, and tissue (including plasma) levels
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of copper were evaluated, it was found in our earlier studies
that the plasma copper levels remained constant while the
other tissue levels continued to drop to fatally low levels.
Why then did the Mo^^ males survive the prescribed short
term copper therapy?
A possible explanation for the survival of the Mo^^ males
after the short term copper therapy would be that the ability
to bypass the affected intestinal cells made copper available
to all tissues and, too, that in this disorder, there is a
secondary recovery of the intestinal mucosal cells. This
secondary recovery would be the biosynthesis of band H and
band DI protein, so that copper can eventually be obtained
from the diet in adequate amounts. Experimental and therapeutic
timing are crucial since the development of the mouse brain
is vastly different from that of the human.
The timing and extent of copper therapy beyond the 14th
postnatal day of Mo males could allow for the adequate
production of a latent hormone which is essential to the
biosynthesis of band H protein. This hormone is or should
be present in the normal and heterozygote Mo , but absent
and inducible in the hemizygote.
Biochemical evidence presented here could facilitate
identification of Mo^^ male offspring before the appearance
of clinical symptoms by use of micro upper gastro intestinal
tract biopsy and the immunoprecipitin test. It might also
be possible to do prenatal screening once the method has been
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worked out for obtaining gastro-intestinal tissue (by lavage)
from potential Menkes mothers and amnionic cells from the
potentially diseased male offspring.
This is the direction of research indicated by our
present data.
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